180 related articles for article (PubMed ID: 498587)
1. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
Casali P; Lambert PH
Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
[TBL] [Abstract][Full Text] [Related]
2. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
3. Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1983 Aug; 53(2):308-18. PubMed ID: 6411401
[TBL] [Abstract][Full Text] [Related]
4. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
Soltis RD; Hasz DE
J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
[TBL] [Abstract][Full Text] [Related]
5. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
[TBL] [Abstract][Full Text] [Related]
8. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
9. Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A.
Gupta RC; Tan EM
Clin Exp Immunol; 1981 Oct; 46(1):9-19. PubMed ID: 7337970
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
12. Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice.
Aguado MT; Mannik M
Immunology; 1987 Feb; 60(2):255-60. PubMed ID: 3817872
[TBL] [Abstract][Full Text] [Related]
13. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
14. Identification of components of IC purified from human sera. I. Immune complexes purified from sera of patients with SLE.
Maire MA; Barnet M; Carpentier N; Miescher PA; Lambert PH
Clin Exp Immunol; 1983 Feb; 51(2):215-24. PubMed ID: 6839539
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific detection of soluble immune complexes in conglutinin-binding assays.
D'Amelio R; Brighouse G; Barnet M; Lambert PH
Clin Exp Immunol; 1981 Aug; 45(2):283-9. PubMed ID: 7318255
[TBL] [Abstract][Full Text] [Related]
16. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
17. Possible mechanisms of degradation of C1q in vivo and in vitro: role of macrophages.
Daha MR
Behring Inst Mitt; 1989 Jul; (84):42-6. PubMed ID: 2529843
[TBL] [Abstract][Full Text] [Related]
18. Immune complexes in patients with drug eruptions: the relationship between skin lesions and circulating immune complexes.
Yanase K; Imamura S
Clin Exp Immunol; 1980 Sep; 41(3):471-7. PubMed ID: 6449338
[TBL] [Abstract][Full Text] [Related]
19. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
Belozerov AP
Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
[TBL] [Abstract][Full Text] [Related]
20. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
